Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SCOTTSDALE, Ariz., June 29, 2011 /- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix® II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears. CrossFix® II will be on display at the 2011...

ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 29, 2011 /- ZONARE Medical Systems, a global developer of high-end ultrasound systems, today announced it ranked highest in performance across a number of clinical applications and ranked first or second in several customer support and service categories in the...

UBM Canon Announces New Japanese-Language Website for Japan Medical Design & Manufacturing Technology:

June 29, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, June 29, 2011 /- UBM Canon's leading brand, Japan Medical Design & Manufacturing Technology ( JMD&MT ) today announced the launch of its new Japanese-language website with enhanced content and functionality at . "This new website allows users to find the...


Unilife Successfully Completes Industrialization of Unifill Syringe

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

YORK, Pa., June 29, 2011 /- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ; ASX: UNS) today announced that it has successfully completed the validation phase of the Unifill® ready-to-fill (prefilled) syringe. This key industrial milestone represents the final step in...

United Lincolnshire Hospitals NHS Trust Selects Jayex QI Interactive Patient Survey and Information Management Kiosk

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

LONDON, June 29, 2011 /-   - Jayex ' s QI Touch Screen Solution Enables the Trust to Instantly Review Patient Feedback to Assist in the Delivery of High-Quality Patient Centred Care - Jayex, the healthcare display technology specialist, today announces that...

Perrigo Provides Update on Acquisition of Paddock Labs

June 29, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich., June 29, 2011 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it continues to work to finalize  the regulatory approvals necessary to complete the acquisition of Paddock Laboratories, Inc. ("Paddock"), a privately-held, Minneapolis-based pharmaceutical...

Bioengineers expanding work to solve cardiovascular health challenges

June 29, 2011 3:33 am | by Arizona State University | News | Comments

Three ASU bioengineers will expand their research into treatment of brain aneurysms and cardiovascular ailments with support from the American Heart Associationread more

CardioFocus HeartLightâ„¢ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., June 29, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today  that its technology was featured in a live case and scientific abstract presented at the...


Concord Medical Services Files 2010 Annual Report on Form 20-F

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

BEIJING, June 29, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that on June 28, 2011, it filed...

DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., June 29, 2011 /- In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program.  NASA recently followed that...

Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstageâ„¢ GCC Colorectal Cancer Staging Test

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK and QUEBEC CITY, June 29, 2011 /- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc. (TSX: CUR), a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a...

Amsterdam Molecular Therapeutics' Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients

June 28, 2011 11:31 pm | by Bio-Medicine.Org | News | Comments

AMSTERDAM, June 29, 2011 /- Data Presented at the 79 th European Atherosclerosis Society Meeting Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today released data showing that its gene therapy Glybera® (alipogene tiparvovec)...

Burlington Medical Supplies Introduces Single Swing-Arm Drape

June 28, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEWPORT NEWS, Va., June 28, 2011 /-  Burlington Medical Supplies, headquartered in Newport News, Virginia, has introduced a new product into its inventory. The Single Swing-Arm Drape attaches to a medical procedure table's arm extension and protects the worker from any scattered...


The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients

June 28, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., June 28, 2011 /- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of...

Sanofi Pasteur Commends Winners of International BioGENEius Challenge

June 28, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SWIFTWATER, Pa., June 28, 2011 /- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY ), offers its congratulations to the four winners of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of...

FDA Consumer Health Information - FDA's MedWatch Safety Alerts: May 2011

June 28, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 28, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including: (Logo: ) birth control pills that may increase the risk of blood...

New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients

June 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 28, 2011 /- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart...

Aeris Therapeutics names new CFO Carter

June 28, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Aeris Therapeutics LLC, a Woburn-based drug developer focused on treatments for emphysema and other advanced lung diseases, has appointed a new chief financial officer in Charles R. Carter.

Patients Treated with Sunitinib and Sorafenib Respond to Flu Vaccine

June 28, 2011 9:34 am | by AACR | News | Comments

Tweet   • Flu vaccine could be used to test immune response. • Patients presented with metastatic renal cell cancer. • Implications beyond quality of life and patient management. PHILADELPHIA - Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests...

Lutonix Announces Achievement of Significant Milestones and Additions to Executive Leadership Team

June 28, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, June 28, 2011 /- Lutonix today announced receiving approval from the US Food and Drug Administration to begin enrollment in its LEVANT 2 IDE clinical trial for the treatment of peripheral arterial disease (PAD), along with receipt of CE Mark for its drug-coated balloon and...

Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011

June 28, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., June 28, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to...

Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform

June 28, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

RESTON, Va., June 28, 2011 /- The Mirixa Corporation and the Canadian Association of Chain Drug Stores (CACDS) are pleased to announce that MirixaPro(SM), a Web-based clinical platform that supports and documents standardized, pharmacy-based patient care service delivery, will be deployed...

Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men

June 28, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 28, 2011 /- Eli Lilly and Company (NYSE: LLY ) announced that a pivotal Phase III Axiron study, published on the Clinical Endocrinology website, showed that Axiron® (testosterone) topical solution CIII, when applied to the underarm, met the primary study objective...

Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease

June 28, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

HOBOKEN, N.J., June 28, 2011 /- Octapharma USA recently hosted an International Physician Advisory Board in New York City, bringing together medical experts from around the world who have extensive experience internationally with taking care of patients with von Willebrand's Disease...

IBM Study Identifies New Generation of Connected Health Devices

June 28, 2011 7:37 am | by IBM | News | Comments

Consumers have a growing appetite for health and wellness devices, and this represents a burgeoning market opportunity for device manufacturers that has barely been tapped, according to a study from IBM (NYSE: IBM). The company also unveiled a list of possible wellness device innovations...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.